Glick, Brad, Edward Lain, Tina Lin, and Robert Israel. 2019. “Efficacy of Halobetasol 0.01%/Tazarotene 0.045% (HP/TAZ) Fixed Combination in the Treatment of Moderate Plaque Psoriasis: Indirect Comparison Between Pooled Phase 3 Trials of HP/TAZ and Oral Treatment (Apremilast)”. SKIN The Journal of Cutaneous Medicine 3 (November):S30. https://doi.org/10.25251/skin.3.supp.30.